Literature DB >> 25439697

Local treatments for metastases of renal cell carcinoma: a systematic review.

Saeed Dabestani1, Lorenzo Marconi2, Fabian Hofmann3, Fiona Stewart4, Thomas B L Lam4, Steven E Canfield5, Michael Staehler6, Thomas Powles7, Börje Ljungberg8, Axel Bex9.   

Abstract

Local treatment of metastases such as metastasectomy or radiotherapy remains controversial in the treatment of metastatic renal cell carcinoma. To investigate the benefits and harms of various local treatments, we did a systematic review of all types of comparative studies on local treatment of metastases from renal cell carcinoma in any organ. Interventions included metastasectomy, radiotherapy modalities, and no local treatment. The results suggest that patients treated with complete metastasectomy have better survival and symptom control (including pain relief in bone metastases) than those treated with either incomplete or no metastasectomy. Nevertheless, the available evidence was marred by high risks of bias and confounding across all studies. Although the findings presented here should be interpreted with caution, they and the identified gaps in knowledge should provide guidance for clinicians and researchers, and directions for further research.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25439697     DOI: 10.1016/S1470-2045(14)70235-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  82 in total

1.  Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients.

Authors:  Y A M Kuijpers; R P Meijer; G N Jonges; J de Jong; J L H R Bosch; S Horenblas; A Bex
Journal:  World J Urol       Date:  2016-04-07       Impact factor: 4.226

2.  Unmarried status is a barrier for access to treatment in patients with metastatic renal cell carcinoma.

Authors:  Giuseppe Rosiello; Sophie Knipper; Carlotta Palumbo; Cristina Dzyuba-Negrean; Angela Pecoraro; Elio Mazzone; Francesco A Mistretta; Zhe Tian; Umberto Capitanio; Francesco Montorsi; Shahrokh F Shariat; Fred Saad; Alberto Briganti; Pierre I Karakiewicz
Journal:  Int Urol Nephrol       Date:  2019-08-29       Impact factor: 2.370

3.  Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea.

Authors:  Jeong Ho Kim; Wan Lee; Tae Nam Kim; Jong Kil Nam; Tae Hyo Kim; Ki Soo Lee
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

4.  External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.

Authors:  Lorenzo Marconi; Roderick de Bruijn; Erik van Werkhoven; Christian Beisland; Kate Fife; Axel Heidenreich; Anil Kapoor; Jose Karam; Caroline Kauffmann; Tobias Klatte; Boerje Ljungberg; Surena Matin; Daniel Sjoberg; Michael Staehler; Grant D Stewart; Simon Tanguay; Robert Uzzo; Sarah Welsh; Lori Wood; Chris Wood; Axel Bex
Journal:  World J Urol       Date:  2018-08-01       Impact factor: 4.226

5.  Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.

Authors:  Dalsan You; Chunwoo Lee; In Gab Jeong; Cheryn Song; Jae-Lyun Lee; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-23       Impact factor: 4.553

Review 6.  Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data.

Authors:  Jacqueline M Speed; Quoc-Dien Trinh; Toni K Choueiri; Maxine Sun
Journal:  Curr Urol Rep       Date:  2017-02       Impact factor: 3.092

Review 7.  Post partial nephrectomy surveillance imaging: an evidence-based approach.

Authors:  Lorenzo Marconi; Michael A Gorin; Mohamad E Allaf
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

8.  Surgical metastasectomy for renal cell carcinoma: which patients are the real candidates for surgery?

Authors:  Satoshi Kato; Satoru Demura; Hideki Murakami; Hiroyuki Tsuchiya
Journal:  Ann Transl Med       Date:  2019-12

9.  Lack of evidence regarding bone metastases of genitourinary cancers: interventions by surgery, radiotherapy, and bone-targeted systemic therapy.

Authors:  Makito Miyake; Takuya Owari; Kiyohide Fujimoto
Journal:  Ann Transl Med       Date:  2019-07

10.  Demethylation of miR-10b plays a suppressive role in ccRCC cells.

Authors:  Cheng He; Xiaokun Zhao; Hongyi Jiang; Zhaohui Zhong; Ran Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.